HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100CompaniesDeal TrackerResearch
Biotech

Spero Therapeutics, Inc.

1
Articles
Mentioned
Top Role
Apr 11, 2026
First Mention
Apr 11, 2026
Last Mention
0.95
Relevance Score

Coverage Timeline

April 2026
AI-Discovered Antibiotics Hit the Clinic: Hype, Resistance, and the Harsh Economics Pipeline Mentioned
Apr 11, 2026
Instead, most likely buyers will remain the specialty pharma set, think Spero or Paratek, or public sector buyers operating out of BARDA and the UK’s subscription pilot.
Related Companies
Paratek Pharmaceuticals, Inc.
1 shared
Iktos
1 shared
Insilico Medicine
1 shared
Merck & Co., Inc.
1 shared
Pfizer Inc.
1 shared